Skip to content
ppharmaranks
Menu

Mecasermin Rinfabate Recombinant: uses, dosing, side effects & brands

Mecasermin Rinfabate Recombinant is a medicine sold in the U.S. under one brand. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.

By the pharmaranks editorial teamReviewed against the FDA (openFDA label, NDC Directory & Enforcement) sourcesUpdated Jul 24, 2026How we research

Key facts

Available as
Injectable
Sold as
Iplex
Prescription?
Prescription only
Generic available?
Not in our catalog

Every mecasermin rinfabate recombinant product we track (1)

Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.

Only one: Iplex.

Related calculators

Frequently asked questions

Can you take mecasermin rinfabate recombinant with other medicines?

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run mecasermin rinfabate recombinant against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

What forms does mecasermin rinfabate recombinant come in?

Across the brands we track, mecasermin rinfabate recombinant is currently marketed as injectable, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Is there a generic mecasermin rinfabate recombinant?

We do not currently list a generic-labelled mecasermin rinfabate recombinant product. That does not always mean none exists — it means none appears under a generic name in the FDA data we track. Ask your pharmacist.

Cite this page
APA
pharmaranks. (2026, July 24). Mecasermin Rinfabate Recombinant: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/mecasermin-rinfabate-recombinant
MLA
“Mecasermin Rinfabate Recombinant: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/mecasermin-rinfabate-recombinant.

We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.

Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.

Read the full FDA label for mecasermin rinfabate recombinant on DailyMed (NIH) ↗.